Viridans streptococci

Streptococcus viridans 01

Viridans streptococci are a group of Streptococcus species that are part of the normal flora of the human mouth, throat, digestive tract, and urogenital tract. Unlike other streptococci, such as Streptococcus pyogenes (group A strep) which can cause strep throat, or Streptococcus pneumoniae which causes pneumonia, viridans streptococci are typically not highly pathogenic. However, they can be opportunistic pathogens, causing diseases such as bacteremia, endocarditis, and dental infections like dental caries and periodontal disease.

Characteristics

Viridans streptococci are characterized by their ability to produce a greenish color when cultured on blood agar, a trait that is due to the partial hemolysis of red blood cells, known as alpha-hemolysis. This characteristic is the origin of the name "viridans," from the Latin "viridis" meaning green. These bacteria are gram-positive, facultative anaerobes that vary in shape from spherical to ovoid and tend to form chains.

Classification

The viridans group includes several species and is divided into different groups based on genetic, biochemical, and physiological characteristics. Some of the main groups include the Streptococcus mutans group, known for its role in dental caries, and the Streptococcus sanguinis group, which is associated with endocarditis. Other notable groups include Streptococcus salivarius, Streptococcus mitis, and Streptococcus bovis.

Pathogenicity

While viridans streptococci are generally commensals, they can become pathogenic under certain conditions, particularly when they gain access to sterile areas of the body. In individuals with compromised immune systems or damaged heart valves, these bacteria can cause serious infections. Infective endocarditis, a life-threatening infection of the heart valves, is the most significant disease caused by viridans streptococci. They can also cause bacteremia, especially after dental procedures, which can lead to further systemic infections.

Prevention and Treatment

Preventive measures against infections caused by viridans streptococci include maintaining good oral hygiene and, for individuals at high risk of endocarditis, taking prophylactic antibiotics before undergoing dental procedures. Treatment of infections involves the use of antibiotics, with the choice of antibiotic depending on the sensitivity profile of the bacteria. Penicillin is often effective, but resistance has been increasing, necessitating the use of other antibiotics such as vancomycin or linezolid in some cases.

Research and Future Directions

Research on viridans streptococci continues to focus on understanding their mechanisms of pathogenicity, antibiotic resistance patterns, and potential roles in human health beyond their pathogenic capabilities. Studies on the microbiome are also shedding light on the complex interactions between viridans streptococci and other microorganisms in the body, which may have implications for disease prevention and treatment.

‎